Google (NASDAQ: GOOGL ) (NASDAQ: GOOG )
has started making a significant push into wearables, with
medical/health care-related applications among the prime targets. Some
readers may already have heard of the company's efforts to develop a
glucose-sensing smart contact lens that could continuously monitor
glucose levels and interface with mobile devices, allowing diabetics
more freedom and convenience.
Count eye care giant Novartis (NYSE: NVS )
among those who have noticed. Novartis and Google announced on Tuesday
that they would work together on smart contact lenses targeting both
glucose monitoring and presbyopia. It's hard to say how close to reality
(or clinical trials) a functional device might be, but this partnership
just may change the landscape of the glucose monitoring market
presently dominated by companies like Johnson & Johnson (NYSE: JNJ ) , Abbott Labs, Roche and Medtronic.
Read the full article here:
Why Google Could Transform How We See
No comments:
Post a Comment